Detail View

DC Field Value Language
dc.contributor.author Cho, Hyun-Ji -
dc.contributor.author Ryu, Sung Jin -
dc.contributor.author Kim, Byung Ju -
dc.contributor.author Hwang, Jeong-A -
dc.contributor.author Yun, Ahyeon -
dc.contributor.author Kim, Eok-Cheon -
dc.contributor.author Kim, Jae-Ryong -
dc.contributor.author Park, Tae Jun -
dc.contributor.author Lee, Sung Bae -
dc.contributor.author Kim, Young Zoon -
dc.contributor.author Lee, Yun-Il -
dc.contributor.author Park, Sang Chul -
dc.contributor.author Lee, Young-Sam -
dc.date.accessioned 2026-11-17T15:40:14Z -
dc.date.available 2026-11-17T15:40:14Z -
dc.date.created 2026-11-12 -
dc.date.issued 2026-11 -
dc.identifier.issn 0753-3322 -
dc.identifier.uri https://scholar.dgist.ac.kr/handle/20.500.11750/61179 -
dc.description.abstract Receptor tyrosine kinases are critical regulators of cell survival, mediating responses to environmental changes and maintaining biological responsiveness. However, despite growing interest in developing senolytics that target survival factors in senescent cells as a promising strategy to overcome age-related diseases, the therapeutic potential of RTKs in senescence remains largely unexplored. In this study, we aimed to identify senolytic compounds that modulate RTK signaling and ameliorate age-related phenotypes by selectively inducing senescent cell death. Using a drug screening approach, we identified sunitinib, a multi-targeted RTK inhibitor that effectively suppresses PDGFR activation and induces apoptosis specifically in senescent HDFs (sHDFs) by activating caspase-9, −3, and −7. Moreover, in a mouse model of bleomycin-induced lung fibrosis in which senescent cells accumulate in the tissue, sunitinib reduced senescent cells and suppressed SASP expression. These findings, together with the observed increase in PDGFRβ phosphorylation in aged cells, led us to hypothesize that modulating PDGFRβ activity could induce senolysis. Indeed, knockdown of PDGFRβ expression sensitized senescent cells to cell death, with minimal effects on non-senescent HDFs (nsHDFs). At the mechanistic level, PDGFRβ and its downstream pathways, including the JAK2-STAT3 pathway, contributed to the senolytic response to sunitinib. Notably, sunitinib-induced JAK1 phosphorylation contributed to resistance to sunitinib in nsHDFs. Our findings suggest that sunitinib is a promising senolytic agent and that targeting PDGFRβ may represent a previously unknown approach to senolytics. Therefore, our study may provide a potential therapeutic strategy for age-related diseases associated with chronic inflammation. -
dc.publisher Elsevier Masson s.r.l. -
dc.title Sunitinib induces senolysis associated with modulation of platelet-derived growth factor receptor beta -
dc.type Article -
dc.identifier.doi 10.1016/j.biopha.2026.119970 -
dc.identifier.scopusid 2-s2.0-105052393512 -
dc.identifier.bibliographicCitation Biomedicine and Pharmacotherapy, v.204 -
dc.description.isOpenAccess FALSE -
dc.subject.keywordAuthor Cellular senescence -
dc.subject.keywordAuthor Lung fibrosis -
dc.subject.keywordAuthor PDGFRβ -
dc.subject.keywordAuthor Senolysis -
dc.subject.keywordAuthor Sunitinib -
dc.citation.title Biomedicine and Pharmacotherapy -
dc.citation.volume 204 -
dc.description.journalRegisteredClass scopus -
dc.type.docType Article -
Show Simple Item Record

File Downloads

  • There are no files associated with this item.

공유

qrcode
공유하기

Related Researcher

이성배
Lee, Sung Bae이성배

Department of Brain Sciences

read more

Total Views & Downloads

???jsp.display-item.statistics.view???: , ???jsp.display-item.statistics.download???: